Johnston, Tom H <br/><br/>
The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Oct 2010 
 - 2084-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1531-8257 
<br/><br/><label>Standard No.: </label>10.1002/mds.23172  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Antagonists--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Disability Evaluation<br/>Disease Models, Animal<br/>Dopamine Agents--adverse effects<br/>Drug Therapy, Combination--methods<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Female<br/>Imidazoles--pharmacology<br/>Indans--pharmacology<br/>Levodopa--adverse effects<br/>Macaca fascicularis<br/>Male<br/>Motor Activity--drug effects<br/>Parkinsonian Disorders--drug therapy<br/>Time Factors